Link to Register for the Event: http://Innovateocularoncology.com

Event Website: http://Innovateocularoncology.com

INNOVATE Ocular Oncology continues in the tradition of our INNOVATE series, where scientific, clinical, and industry leaders come together to educate and inform participants on the state-of-the-art and future trends in ocular oncology. This is a critical time in this field- even with the approval of new therapies, increased clinical trial options, and advanced diagnostics, there are still unmet needs regarding treatment burden, toxicities, and access to care. INNOVATE Ocular Oncology aims to address these issues head-on with provocative lectures, cutting-edge research presentations, and panel discussions with leaders in biopharma. The hallmark of this meeting rests with hard questions, lively debate, and a collegial inter-disciplinary environment.

Event Details: Topic highlights:

• Liquid biopsy: beyond just diagnosis.

• Adjuvant therapeutics in uveal melanoma: promises for the future.

• New FDA approvals in ocular oncology: unmet needs.

• Tailoring therapy in complex disease: intraocular lymphoma.

• Radiation toxicities: old problems, new strategies.

• Black box warnings: drug toxicities and management strategies.

• New directions in retinoblastoma therapies.

• Conversations in drug development: industry leaders share insights into the ocular oncology space